top of page

ClearSky heads to 2022 MDS International Congress in Madrid

The ClearSky Medical Diagnostics team will be attending the International Parkinson and Movement Disorder Society (MDS) Congress in Spain this September.

After two years of virtual events, the 2022 MDS Congress returns as a hybrid event – taking place virtually and in-person at the Madrid Marriott Auditorium Hotel from 15 to 18 September.

Delegates at the Congress will gather together to learn about the latest advancements and research in the field of movement disorders. This includes Professor Stephen Smith, our co-founder and MD, who will be at the Congress – so do pop by to say hello at Booth 104.

MDS is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson’s, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.

The aim of the world-leading international Congress is to share ideas, encourage interest among all those involved in the care and research of movement disorders, and to advance the related clinical and scientific discipline.

If you would like to chat about our technology for diagnosing and monitoring neurodegenerative conditions, including Parkinson’s and Alzheimer’s, please get in touch.

10 views0 comments


bottom of page